STAT
STAT+: Kennedy’s split-screen week: Talk of vaccines in D.C., fraud and addiction out West
STAT PlusPolitics Kennedy’s split-screen week: Talk of vaccines in D.C., fraud and addiction out West In California,…
health · source
STAT News on WeSearch
Recent health headlines from STAT News.
STAT
STAT+: State laws may be curbing private equity takeovers of physician group
Private equity deals for practice management firms are declining sharply.
STAT
STAT+: FDA approves Bristol multiple myeloma treatment, marking debut of novel drug class
The FDA approved a treatment for advanced multiple myeloma made by Bristol Myers Squibb, marking the debut of a new…
STAT
STAT+: An investigation into Commure, and Medicare’s new-tech incentives for AI devices
In this edition of STAT Health Tech: a deep dive into General Catalyst-backed Commure, and Medicare's tech incentives…
STAT
Opinion: How should states reach out to Medicaid enrollees affected by changes? Our research gives a hint
Experts ask: How can we better reach out to people facing Medicaid renewal deadlines and support them through the…
STAT
STAT+: The promise of radiopharmaceuticals smacks into safety concerns
Despite excitement over the potential of radiopharmaceuticals as cancer treatments, drug developers are hitting new…
STAT
Opinion: We prepared for Ebola — but not this Ebola
“Preparedness cannot mean optimizing every investment for yesterday's epidemic,” write Krutika Kuppalli and Placide…
STAT
STAT+: China tightens the reins on clinical trials, even as the U.S. looks for ways to replicate its rival’s speed
China has tightened regulations on investigator-initiated trials, with consequences not just for Chinese researchers…
STAT
STAT+: A shortage of two Sanofi medicines for Pompe disease rattles patients
Sanofi is experiencing shortages of two medicines for Pompe disease, alarming patient groups.
STAT
STAT+: NIH plans to block international researchers on visas from accessing key funding avenue
The NIH plans to close the door on one of the few pathways available to international students on visas to forge a…
STAT
Opinion: One year since Kennedy canceled mRNA vaccine projects, science shows how wrong he was
“The United States invented this platform and is the only country walking away from it,” Jeff Coller writes of mRNA…
STAT
STAT+: Why Schrödinger CEO Ramy Farid changed how he’s thinking about AI
In this edition of STAT's AI Prognosis: Why Schrödinger CEO Ramy Farid is rethinking AI, Recursion's neuron map, and…
STAT
STAT+: Moderna launches early trial of Ebola mRNA vaccine
Novo and Lilly earnings are out, Aurora Therapeutics slashing staff, and more biotech news from The Readout
STAT
Opinion: Something is missing from movies about medical aid in dying
Films and documentaries about assisted dying can narrow the frame of debate, write Anna Magdalena Elsner and Vanessa…
STAT
Opinion: Tear down the wall between M.D. and D.O. education
Having separate systems for M.D.s and D.O.s “is historical inertia dressed as educational diversity,” write physicians…
STAT
MRI is standard for diagnosing prostate cancer in most western countries. But most U.S. men don’t get them
Pre-biopsy MRI is standard outside the U.S., but the latest data show such scans were done in only about a third of…
STAT
STAT+: Senate inquiry suggests Trump administration softened kratom and tobacco policies in quid pro quo
The Senate investigation includes RFK Jr. as well as the heads of Reynolds American and kratom company Botanic Tonics,…
STAT
STAT+: Exemption of rare disease therapies in drug-pricing pilots would wipe out huge savings, analysis finds
Excluding rare disease therapies from a Medicare pilot program to lower drug prices would wipe out much of the savings…
STAT
Ebola kills 1,700 in eastern Congo as the fastest-growing outbreak surges
Ebola has killed more than 1,700 people in eastern Congo in what has become the fastest-growing outbreak of the disease.
STAT
STAT+: California Supreme Court sides with Gilead in ‘duty’ to innovate case
The California Supreme Court sided with Gilead Sciences in a closely watched case over whether the company had a…
STAT
STAT+: Pharmalittle: We’re reading about AstraZeneca-Bristol merger talks, a revised 340B plan, and more
AstraZeneca stock fell as investors balked at reports of merger talks with Bristol Myers Squibb about forming one of…
STAT
New York’s assisted-dying law moves forward
Medicaid work requirements in effect in Nebraska, AI scribes in med school, and more health news from Morning Rounds
STAT
STAT+: BioNTech names Guido Oelkers its new CEO
Guido Oelkers will take over as the new CEO of BioNTech, replacing company cofounder Ugur Sahin.
STAT
STAT+: Michigan Supreme Court ruling allows probe into Lilly insulin pricing
Lilly was accused of charging “grossly” excessive prices for different insulin products that forced some patients to…
STAT
Syphilis spreads while researchers contend with federal constraints and a drug shortage
Manage alerts for this article Email this article Share this article Highlights UCSD researchers have spent years…
STAT
Opinion: What a recent op-ed got wrong about our Covid study
“The appropriate counter to Covid revisionism is careful, rigorous, and honest assessment of the U.S. response.”
STAT
Opinion: Limb girdle muscular dystrophy patients face a maddening reality
“Too often, regulatory tools authorized to speed patient access to breakthrough treatments are being used in ways that…
STAT
Opinion: We once praised the American Diabetes Association’s courage. How things have changed
“The ADA is no longer what we’d call a profile in courage,” write Adam Marcus and Ivan Oransky of Retraction Watch.
STAT
Capricor’s data clash and a fugitive in the C-suite
Is the FDA taking inconsistent approaches to Duchenne drugs? And how will a new batch of drug executives shake up…
STAT
Key Senate panel backs Trump’s picks for CDC, pandemic preparedness
In win for RFK Jr., Senate committee sends nominations of Erica Schwartz for CDC director and Sean Kaufman for ASPR to…
STAT
Judge denies states’ motion to postpone Medicaid work requirement
Federal judge denied 26 states’ request to postpone the implementation of Medicaid work requirements announced in June.
STAT
Ebola outbreak nears milestone, but vaccine is close
You can reach Theresa on Signal at theresagaff.97.Helen BranswellHelen Branswell covers issues broadly related to…
STAT
Is it safe to drink Red Bull and vodka? Questionable research tied to energy drink giant has shaped policy
Studies tied to Red Bull helped block warning labels about drinking alcohol along with energy drinks. Independent…
STAT
A neglected issue in pedestrian, biker deaths
You can reach Theresa on Signal at theresagaff.97. Might I suggest you order yourself a delicious sandwich for lunch…
STAT
Fauci invokes Fifth Amendment in declining to answer questions before Senate panel
At a highly anticipated Senate hearing, Anthony Fauci evoked his Fifth Amendment right to refuse to answer questions…
STAT
STAT+: American Diabetes Association, facing calls for resignations, asks for patience
An open letter to the board of the American Diabetes Association said the board had badly mishandled an incident at…
STAT
Visa time limits on foreign Ph.D. students and postdocs will harm U.S. science, experts warn
You can reach Jonathan on Signal at jwosen.27. For nearly half a century, the federal government encouraged…
STAT
STAT+: Bracing for another Fauci hearing
Plus: Democrats take on Trump over IVF, and Trump's White House releases a new science funding blueprint.
STAT
STAT+: GSK lays out plans to cut costs, pursue more late-stage drug trials
New GSK CEO Luke Miels outlined his strategy to help the company navigate a patent cliff and get on a path toward…
STAT
STAT+: Three questions with Whoop’s new CMO
In this edition of STAT Health Tech: A chat with Whoop's new chief medical officer, an update on CMS health tech…
STAT
STAT+: Pharmalittle: We’re reading about FDA views on a Duchenne drug, GSK cost savings, and more
The FDA said a Capricor stem cell treatment for Duchenne muscular dystrophy did not meet a Phase 3 trial's objectives…
STAT
CMS evaluates one year of health tech progress, announces eight new pledge categories
The Centers for Medicaid and Medicare Services marked one year of its Health Tech Ecosystem initiative, unveiling…
STAT
Opinion: STAT+: Dementia finally has a business model
The article reflects on the shift in perspective at the 2026 Alzheimer’s Association International Conference, noting…
STAT
From ‘lost cause’ to gold rush: Biotechs swarm to cure AATD
Biotech companies are racing to cure alpha-1 antitrypsin deficiency, AATD, fueling patent disputes, startup…
STAT
STAT+: HIV resurgence is feared as global funding to combat the disease falls 18%
The world risks a resurgence of the HIV epidemic after international financing to combat the disease suffered a…
STAT
STAT+: RA Capital backs upstart rival to Ultragenyx and Ionis in rare brain disease
Confidential tips can be sent on Signal at JasonMast.77. RA Capital and a fleet of other investors are putting $175…
STAT
STAT+: Pharmalittle: We’re reading about a U.S. peptide panel’s votes, Amgen scuffling with the FDA, and more
Good morning, everyone, and welcome to another working week. We hope the weekend respite was relaxing and invigorating…
STAT
STAT+: Ahead of hearing, FDA questions the efficacy of Capricor’s Duchenne drug
Ahead of a hearing, the FDA raised questions about the benefits of a Duchenne treatment from Capricor Therapeutics,…
STAT
A trend that isn’t fading, ultra-processed baby foods
An FDA advisory panel serves some peptide wins, a measles record, and more health news from Morning Rounds
STAT
STAT+: Argenx to buy Forte Biosciences for $2.2B
Argenx plans to buy Forte Biosciences for $2.2 billion, expanding its pipeline of drugs that could treat multiple…
How WeSearch handles this source
WeSearch's declared handling of STAT News's content. Indexing, snippets, summaries, retrieval and training are separate questions — see the rights registry or read this source's machine-readable record.
Indexing: Allowed
Snippet: Allowed
AI summary: Limited
Retrieval / RAG: Not asserted
Model training: Not asserted
Commercial reuse: Not permitted